This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Central nervous system
Central nervous system
Pathophysiology of cystic fibrosis: an overview
Gilenya shows significant early effect on reducing brain volume loss
AMPYRA® two-year safety data
Novartis MS portfolio presence at 28th ECTRIMS
Peripheral nerve stimulation study
World Alzheimer’s Day: EAHP president highlights the need for dementia-friendly health systems
MRI findings dispute blood flow and MS correlation
EC approves KALYDECO™ for cystic fibrosis
HRT ‘still acceptable for menopausal symptoms’
Nevirapine efficacious in African women with HIV
Another MS pill submitted to EMA for approval
Gilenya safety and efficacy ‘consistent for 4.5 years’
« Previous
1
…
5
6
7
8
9
…
27
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: